AM-Pharma's Series C Round

AM-Pharma raised a round of funding on May 09, 2008.

AM-Pharma is a biopharmaceutical company focused on the pre-clinical and clinical development of Alkaline Phosphatase to treat severe conditions where inflammation plays an important role. The product…

Articles about AM-Pharma's Series C Round: